Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document.

standard chartered

STANDARD CHARTERED PLC

渣打集團有限公司

(Incorporated as a public limited company in England and Wales with limited liability)

(Registered Number: 966425)

(Stock Code: 02888)

Notice of Annual General Meeting 2026

NOTICE IS HEREBY GIVEN THAT the Annual General Meeting 2026 will be held at The Honourable Artillery Company (HAC), Armoury House, West Gate, Bunhill Row, London EC1Y 2BQ on Thursday 7 May 2026 at 11.00am UK time.

You will be asked to consider the following resolutions.

Resolutions 1 to 19 (inclusive) are proposed as ordinary resolutions, which must each receive more than 50 per cent of the votes cast in order to pass. Resolutions 20 to 25 (inclusive) are proposed as special resolutions, which must each receive at least 75 per cent of the votes cast in order to pass. Please note that a vote 'withheld' is not a vote in law and will not be counted in the calculation of the proportion of votes 'for' or 'against' a resolution.

The results of the voting on the resolutions at the AGM will be announced to the London Stock Exchange and The Stock Exchange of Hong Kong Limited (Hong Kong Stock Exchange), and published on our website sc.com/agm following the conclusion of the meeting.

At the date of this document, no shares are held by the Company in treasury. Unless otherwise stated, references in this document to: (i) the issued ordinary share capital of the Company are to the issued ordinary share capital of the Company (2,243,710,167 ordinary shares) as at 13 March 2026 (being the latest practicable date prior to the publication of this document (the Latest Practicable Date)); and (ii) $ and cents are to US dollar and cents, respectively.

Ordinary Resolutions

Annual Report and Accounts

To receive the Company's annual report and accounts for the financial year ended 31 December 2025 together with the reports of the directors and auditors.

The purpose of this resolution is for shareholders to receive and consider the audited annual accounts and the reports of the directors and auditors of the Company for the year ended 31 December 2025.

Final Dividend

To declare a final dividend of 49 cents per ordinary share for the year ended 31 December 2025.

If shareholders approve resolution 2, the final dividend of 49 cents per ordinary share will be paid in either sterling, Hong Kong dollars or US dollars on 14 May 2026 to shareholders on the UK register of members at 10.00pm UK time on 20 March 2026, and to shareholders on the Hong Kong branch register of members at the opening of business in Hong Kong (9.00am Hong Kong time) on 20 March 2026.

2025 Final Dividend Options

Shareholders will receive their 2025 final year dividend as cash. The options available for receiving your cash dividend and the arrangements for calculating and paying the cash dividend are set out on sc.com/shareholders.

The cash dividend is quoted in US dollars and the amount that shareholders will receive in Hong Kong dollars or sterling is calculated by using the forward US dollar/Hong Kong dollar or US dollar/sterling exchange rate as displayed on the appropriate page of the Bloomberg screen or equivalent at or around 2.00pm (UK time) on 24 April 2026, which will be published on our website at sc.com/shareholders.

The Hong Kong Stock Exchange granted a waiver to the Company on 7 December 2011 from compliance with Rule 13.66(2) of the HKLR and Note 3 thereunder relating to record dates for the Company's final dividend.

Directors' remuneration report

To approve the annual report on directors' remuneration contained in the Directors' Remuneration Report for the year ended 31 December 2025 as set out on pages 180 to 206 of the 2025 annual report and accounts.

The Directors' Remuneration Report sets out the pay and benefits received by each of the directors for the year ended 31 December 2025. The Company is required to seek shareholders' approval for the contents of this report on an annual basis. The vote will be advisory.

Directors' re-election (Resolutions 4 - 13)

In accordance with the UK Corporate Governance Code 2024 all continuing directors will stand for re-election at each AGM. The Board is satisfied that it continues to maintain an appropriate balance of skills, experience and knowledge and that all non-executive directors standing for re-election are independent both of the Company and in character and judgement.

To re-elect by separate resolutions each of:

Shirish Apte as an independent non-executive director
Jackie Hunt as an independent non-executive director
Diane Jurgens as an independent non-executive director
Robin Lawther, CBE as an independent non-executive director
Lincoln Leong as an independent non-executive director
Maria Ramos as Group Chair
Phil Rivett as an independent non-executive director
David Tang as an independent non-executive director
Bill Winters, CBE as an executive director
Dr Linda Yueh, CBE as an independent non-executive director

Each director undergoes a formal evaluation which confirms that they make an effective and valuable contribution to the Board and demonstrate commitment to the role. The Board is satisfied with the outcome of these reviews and recommends each director's re-election.

Appointment of Auditor/Auditor fees

To re-appoint Ernst & Young LLP (EY) as auditor to the Company from the end of the AGM until the end of next year's AGM.

The Board proposes that EY be re-appointed auditor to the Company to hold office from the end of this AGM until the end of next year's AGM.

To authorise the Audit Committee, acting for and on behalf of the Board, to set the remuneration of the auditor.

This resolution seeks shareholders' approval for the Audit Committee to set auditor remuneration. Details of the remuneration paid to the Company's external auditors for 2025 can be found on page 420 of the 2025 annual report and accounts.

Political donations

That in accordance with sections 366 and 367 of the Companies Act 2006 (the Act), the Company and all companies that are its subsidiaries during the period for which this resolution has effect are authorised to:

(A) make donations to political parties and/or independent election candidates not exceeding £100,000 in total;
(B) make donations to political organisations other than political parties not exceeding £100,000 in total; and
(C) incur political expenditure not exceeding £100,000 in total,

(as such terms are defined in sections 363 to 365 of the Act) provided that the aggregate amount of any such donations and expenditure shall not exceed £100,000 during the period beginning with the date of passing of this resolution and expiring at the end of next year's AGM.

The Group's policy is not to make political donations and none were made in the year ended 31 December 2025. However, since the definitions of political donations and political expenditure used in the Act are very wide it is possible that certain routine activities of the Company and its subsidiaries might unintentionally fall within the broad scope of the provisions. Any political donations or expenditure regulated by the Act must be approved by shareholders at a general meeting and be disclosed in the next year's annual report. Accordingly, the directors are seeking shareholders' approval to renew this authority as a precautionary measure to ensure that the Group does not inadvertently breach the provisions in the Act.

The authority being sought will be effective until the end of next year's AGM.

Share allotment authorities

That the Board be authorised to allot shares in the Company and to grant rights to subscribe for or convert any security into shares in the Company:

(A) up to a nominal amount of $224,371,016.50 (such amount to be restricted to the extent that any allotments or grants are made under paragraphs (B) or (C) so that in total no more than $373,951,694.50 can be allotted under paragraphs (A) and (B) and no more than $747,903,389 can be allotted under paragraphs (A), (B) and (C));

(B) up to a nominal amount of $373,951,694.50 (such amount to be restricted to the extent that any allotments or grants are made under paragraphs (A) or (C) so that in total no more than $373,951,694.50 can be allotted under paragraphs (A) and (B) and no more than $747,903,389 can be allotted under paragraphs (A), (B) and (C)), in connection with a scrip dividend scheme or similar arrangement implemented in accordance with the Articles of Association of the Company;

(C) comprising equity securities (as defined in section 560(1) of the Companies Act 2006) up to a nominal amount of $747,903,389 (such amount to be restricted to the extent that any allotments or grants are made under paragraphs (A) or (B) so that in total no more than $747,903,389 can be allotted under paragraphs (A), (B) and (C)) in connection with an offer by way of a rights issue:

(i) to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
(ii) to holders of other equity securities as required by the rights of those securities or as the Board otherwise considers necessary,

and so that the Board may impose any limits or restrictions and make any arrangements which it considers necessary or appropriate to deal with treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or under the laws of, any territory or any other matter; and

(D) pursuant to the terms of any share scheme of the Company or any of its subsidiaries or subsidiary undertakings,

such authorities to apply until the end of next year's AGM (or, if earlier, until the close of business on 6 August 2027) but, in each such case, during this period the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the authority had not ended. For the purposes of the Hong Kong Listing Rules, any reference in this resolution 17 to an allotment or grant of rights to subscribe for, or convert any security into, shares shall be deemed to include a sale or transfer of treasury shares.

This resolution seeks approval to renew the authorities granted to the directors at last year's AGM to allot shares or grant rights to subscribe for or convert any security into shares (collectively Allotments).

Paragraphs (A), (B) and (C) seek authority to make Allotments representing up to a maximum of two-thirds of the total issued ordinary share capital of the Company, broken down as follows:

(A) up to 20 per cent by way of a general power to make Allotments;
(B) a further 13.33 per cent in connection with a scrip dividend only; and
(C) up to two-thirds less any Allotments under (A) and (B), in connection with a rights issue only.

In addition to the authorities under paragraphs (A), (B) and (C), paragraph (D) seeks approval to authorise directors to make Allotments under share schemes operated by any member of the Group.

Under Rule 7.19A(1) of the HKLR, a proposed rights issue that increases either the number of issued shares or the market capitalisation of the Company by more than 50 per cent (on its own or aggregated with rights issues or open offers announced or commenced within the previous 12 months) must be approved by minority shareholders (i.e. shareholders other than (i) any controlling shareholder for the purposes of the HKLR; or (ii) where there are no such controlling shareholders, the executive directors and the Group Chair) in a general meeting by a resolution on which the executive directors, the Group Chair and their respective associates abstain from voting. However, the Hong Kong Stock Exchange granted the Company a waiver from strict compliance on the basis that:

(A) the executive directors, the Group Chair and their respective associates abstain from voting on the relevant resolution at the AGM; and
(B) the Company need not obtain further minority shareholder approval provided that:

(i) the market capitalisation of the Company will not increase by more than 50 per cent as a result of the proposed rights issue; and
(ii) the outcome of the relevant resolution would not have been altered if any new executive directors or new Group Chair appointed since the AGM that were shareholders at the time of the AGM and voted in favour of the resolution had in fact abstained from voting.

Other than for Allotments under the Company's share schemes, the directors have no present intention to exercise the powers sought by resolution 17.

The authorities sought in resolution 17 will expire at the end of next year's AGM (or, if earlier, at the close of business on 6 August 2027).

That the authority granted to the Board pursuant to paragraph (A) of resolution 17 be extended by the addition of such number of ordinary shares of 50 cents each repurchased by the Company under the authority granted pursuant to resolution 23, to the extent that such extension would not result in the authority to allot shares or grant rights to subscribe for or convert securities into shares pursuant to resolution 17 exceeding a nominal amount of $747,903,389.

As permitted by the HKLR, resolution 18 seeks to extend the directors' authority to make Allotments pursuant to paragraph (A) of resolution 17 to include any shares repurchased by the Company under the authority sought by resolution 23.

That, in addition to any authority granted pursuant to resolution 17 (if passed), the Board be authorised to allot shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of $168,278,262.50 (or 336,556,525 shares), representing approximately 15 per cent of the Company's nominal issued ordinary share capital as at the Latest Practicable Date, in relation to any issue by the Company or any subsidiary or subsidiary undertaking of the Company (together, the Group) of Equity Convertible Additional Tier 1 Securities (ECAT1 Securities) that automatically convert into or are exchanged for ordinary shares in the Company in prescribed circumstances where the Board considers that such an issuance of ECAT1 Securities would be desirable in connection with, or for the purposes of complying with or maintaining compliance with the regulatory capital requirements or targets applicable to the Group from time to time, such authority to expire at the end of next year's AGM (or, if earlier, at the close of business on 6 August 2027) but so that, in the period before the authority ends, the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or to convert securities into shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the authority had not ended.

The effect of resolution 19 is to give the Board the authority to make Allotments of ordinary shares in the Company up to approximately 15 per cent of the Company's issued ordinary share capital in connection with the issue of ECAT1 Securities.

Please see the Appendix for more information on ECAT1 Securities. This resolution 19 should also be read together with the notes to resolution 22 which relate to the ability of the Company to allot ECAT1 Securities, and shares issued upon conversion or exchange of ECAT1 Securities, without the need to first offer them to existing shareholders.

The authority sought under resolution 19 is not contemplated by the guidance issued by the Investment Association. The Board may use the authority sought under resolution 19 as it considers desirable to meet the capital needs of the Group. This authority is in addition to the authority proposed under resolution 17.

The authority sought under resolution 19 will expire at the end of next year's AGM (or, if earlier, at the close of business of 6 August 2027). Any part of this authority unused by that date will automatically lapse.

Special Resolutions

Disapplication of Pre-emption rights

That if resolution 17 is passed, the Board be given power to allot equity securities (as defined in the Companies Act 2006 (the Act)) for cash under the authority given by that resolution and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Act did not apply to any such allotment or sale, such power to be limited:

(A) to the allotment of equity securities and sale of treasury shares for cash in connection with a scrip dividend scheme or similar arrangement implemented in accordance with the Articles of Association of the Company;

(B) to the allotment of equity securities and sale of treasury shares for cash in connection with an offer of, or invitation to apply for, equity securities under the authorities granted under paragraphs (A) and (C) of resolution 17 (but in the case of the authority granted under paragraph (C) of resolution 17, by way of a rights issue only):

(i) to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
(ii) to holders of other equity securities, as required by the rights of those securities, or as the Board otherwise considers necessary,

(C) in the case of the authority granted under paragraph (A) of resolution 17, to the allotment (otherwise than under paragraphs (A) and (B) above) of equity securities or sale of treasury shares up to a nominal amount of $56,092,754,

such power to apply until the end of next year's AGM (or, if earlier, until the close of business on 6 August 2027) but, in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the power had not ended.

This resolution would give the directors the authority to allot shares (or sell any shares which the Company holds in treasury) for cash, in the context of a pre-emptive offering (such as a rights issue, open offer or scrip dividend), without first offering them to existing shareholders in proportion to their existing shareholdings, where, for example, legal or practical difficulties in jurisdictions outside the UK may prevent the allocation of shares on a purely pro rata basis. In addition to the above, this resolution would give the directors authority to generally make allotments or sales of up to an aggregate nominal amount of $56,092,754 (representing 112,185,508 ordinary shares of 50 cents each) on a non pre-emptive basis. This represents approximately five per cent of the issued ordinary share capital of the Company.

In respect of the authorities sought under resolutions 20, 21 and 22, the directors acknowledge the provisions of the Pre-Emption Group's most recent Statement of Principles published in November 2022 (the 2022 Statement of Principles). The directors will continue to keep emerging market practice under review but consider that the limits of 5 per cent of the issued ordinary share capital of the Company in resolutions 20 and 21 continue to provide sufficient flexibility to the Company at present.

Other than for Allotments under the Company's share schemes, the directors have no present intention to exercise the powers sought by resolutions 20 and 21. If the powers sought by resolutions 20 and 21 are used in relation to a non-pre-emptive offer, the directors confirm their intention to follow the shareholder protections contained in paragraph 1 of Part 2B of the 2022 Statement of Principles. While the resolution does not specifically provide for follow-on offers, where relevant, the directors confirm their intention to follow the expected features of a follow-on offer as set out in paragraph 3 of Part 2B of the 2022 Statement of Principles.

The authorities sought pursuant to resolution 20 will expire at the end of next year's AGM (or, if earlier, at the close of business on 6 August 2027).

That, if resolution 17 is passed, the Board be given the power in addition to any power granted under resolution 20, to allot equity securities (as defined in the Companies Act 2006 (the Act)) for cash and/or to sell ordinary shares held by the Company as treasury shares for cash under the authority granted under paragraph (A) of resolution 17 as if section 561 of the Act did not apply to any such allotment or sale, such power to be:

(A) limited to the allotment of equity securities or sale of treasury shares up to a nominal amount of $56,092,754; and
(B) used only for the purposes of financing (or refinancing, if the authority is to be used within 12 months after the original transaction) a transaction which the Board determines to be either an acquisition or a specified capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice,

This resolution is intended to give the Company flexibility to make non pre-emptive issues of ordinary shares in connection with acquisitions and other capital investments as contemplated by the 2022 Statement of Principles. The power under this resolution is in addition to that proposed by resolution 20 and would be limited to allotments or sales of an additional five per cent of the issued ordinary share capital of

the Company. In accordance with the 2022 Statement of Principles, the directors confirm that this authority will only be used in connection with an acquisition or specified capital investment that is announced contemporaneously with the issue, or that has taken place in the preceding 12-month period and is disclosed in the announcement of the issue.

The authority sought pursuant to resolution 21 will expire at the end of next year's AGM (or, if earlier, at the close of business on 6 August 2027).

That, in addition to the powers granted pursuant to resolutions 20 and 21 (if passed), and if resolution 19 is passed, the Board be given the power to allot equity securities (as defined in the Companies Act 2006 (the Act)) for cash under the authority given by resolution 19 as if section 561 of the Act did not apply, such authority to apply until the end of next year's AGM (or, if earlier, until the close of business on 6 August 2027) but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or to convert securities into shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the authority had not ended.

The effect of resolution 22 is to give the Board authority to allot ECAT1 Securities without first offering them to existing shareholders. This will allow the Company to manage its capital in the most efficient and economic way for the benefit of shareholders.

If passed, resolution 22 will authorise the Board to make Allotments on a non pre-emptive basis for up to approximately 15 per cent of the Company's issued ordinary share capital, such authority to be exercised in connection with the issue of ECAT1 Securities.

Should a Trigger Event occur (please see the Appendix for more information on ECAT1 Securities and their Trigger Events) the ECAT1 Securities will convert into or be exchanged for shares in the Company. The Board may elect to include within the terms of an ECAT1 Security an option for the Company to give shareholders the opportunity to purchase the ordinary shares created on conversion or exchange of any ECAT1 Securities on a pro rata basis, where practicable and subject to applicable laws, regulations and the terms of each instrument.

The authority sought under resolution 22 will expire at the end of next year's AGM (or, if earlier, at the close of business on 6 August 2027).

Purchase of own Ordinary Shares and Preference Shares

That the Company be authorised for the purposes of section 701 of the Companies Act 2006 (the Act) to make market purchases (as defined in the Act) of its ordinary shares of 50 cents each provided that:

(A) the Company does not purchase more than 224,371,016 shares under this authority;
(B) the Company does not pay less for each share (before expenses) than the nominal value of the share; and
(C) the Company does not pay more for each share (before expenses) than the higher of (i) five per cent over the average of the middle market prices of the ordinary shares according to the Daily Official List of the London Stock Exchange for the five business days immediately before the date on which the Company agrees to buy the shares and (ii) the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out (including when the shares are traded on different trading venues),

such authority to apply until the end of next year's AGM (or, if earlier, until the close of business on 6 August 2027) but during this period the Company may agree to purchase shares where the purchase may not be completed (fully or partly) until after the authority ends and the Company may make a purchase of ordinary shares in accordance with any such agreement as if the authority had not ended. For the purposes of determining compliance with the conditions in paragraphs (B) and (C), the nominal value of the share or the relevant price (respectively) shall, if necessary, be converted into the currency in which the purchase is to be made, calculated by reference to the spot rate of exchange between the currency of the nominal value or of the price (as applicable) and the currency in which the purchase is to be made, as displayed on the appropriate page of the Bloomberg screen (or on the appropriate page of such other information service which publishes that rate from time to time) at or around 11.00am UK time on the business day before the day the Company agrees to buy such share.

The effect of this resolution is to renew the authority granted to the Company to purchase its own shares up to a maximum of 224,371,016 ordinary shares until next year's AGM (or, if earlier, until the close of business on 6 August 2027) at, or between, the minimum and maximum prices specified in this resolution. This is approximately 10 per cent of the Company's issued ordinary share capital. No repurchases of shares will be conducted on the Hong Kong Stock Exchange.

The Company renewed its general authority to purchase its own shares at the 2025 AGM (the 2025 Authority) and announced on 24 February 2026 the intention to commence buying back ordinary shares of 50 cents each with a value of up to $1.5 billion (the 2026 Buyback). Purchases of shares pursuant to the 2026 Buyback commenced on 25 February 2026 and will end no later than 24 August 2026. As at the Latest Practicable Date, the Company had purchased 10,132,520 shares pursuant to the 2026 Buyback under the 2025 Authority. If this resolution is passed, share purchases made pursuant to the 2026 Buyback from the date of this AGM will be made under the authority sought under this resolution.

The directors believe that it is in the best interests of the Company and all of its shareholders to have a general authority for the Company to buy back its ordinary shares in the market in order to provide flexibility in the management of the Company's capital base. The directors intend to keep under review the potential to purchase further ordinary shares. Purchases will only be made if the directors consider that the purchase would be for the benefit of the Company and of its shareholders generally, considering relevant factors and circumstances at that time, for example the effect on earnings per share. The Company may cancel any such shares or hold them in treasury for eventual sale for cash, transfer in connection with an employee share scheme or cancellation. No dividends will be paid on, and no voting rights will be exercised in respect of, shares held in treasury. The directors intend to cancel shares purchased pursuant to this authority or hold them in treasury, subject to market conditions.

The total number of conditional rights and options (whether discretionary or otherwise) to subscribe for ordinary shares outstanding at the Latest Practicable Date, was 81,801,441 which represented 3.65 per cent of the issued ordinary share capital at that date. As at the Latest Practicable Date, there were no warrants over ordinary shares outstanding. If the Company were to purchase the maximum number of ordinary shares permitted under this resolution and under the remaining 2025 Authority, the proportion of ordinary shares subject to outstanding conditional rights and options (whether discretionary or otherwise) would represent approximately 4.31 per cent of the issued ordinary share capital.

That the Company be authorised to make market purchases (as defined in the Companies Act 2006) of up to 15,000 preference shares of $5.00 each and up to 195,285,000 preference shares of £1.00 each provided that:

(A) the Company does not pay less for each share (before expenses) than the nominal value of the share; and
(B) the Company does not pay more for each share (before expenses) than 25 per cent above the following:

(i) in respect of the USD preference shares, the Composite Bloomberg Bond Trader bid price shown on the relevant Bloomberg page ALLQ for the relevant preference share (or any replacement page which displays that price) at or around 11.00am UK time on the business day before the day on which the Company agrees or (if earlier) publicly announces an offer or invitation to buy such share;
(ii) in respect of the GBP preference shares, the London Stock Exchange bid price shown on the relevant Bloomberg page ALLQ for the relevant preference share (or any replacement page which displays that price) at or around 11.00am UK time on the business day before the day on which the Company agrees or (if earlier) publicly announces an offer or invitation to buy such share;
(iii) in respect of either USD or GBP preference shares, where the relevant bid price is not available under (i) or (ii), the highest independent bid price shown on the relevant Bloomberg page ALLQ for the relevant preference share (or any replacement page which displays that price) at or around 11.00am UK time on the business day before the day on which the Company agrees or (if earlier) publicly announces an offer or invitation to buy such share,

such authority to apply until the end of next year's AGM (or, if earlier, until the close of business on 6 August 2027) but during this period the Company may agree to purchase shares where the purchase may not be completed (fully or partly) until after the authority ends and the Company may make a purchase of shares in accordance with any such agreement as if the authority had not ended. For the purposes of determining compliance with the conditions in paragraphs (A) and (B), the nominal value of the share or the relevant price (respectively) shall, if necessary, be converted into the currency in which the purchase is to be made, calculated by reference to the spot rate of exchange between the currency of the nominal value or of the relevant price (as applicable) and the currency in which the purchase is to be made, as displayed on the appropriate page of the Bloomberg screen (or on the appropriate page of such other information service which publishes that rate from time to time) at or around 11.00am UK time on the business day before the day the Company agrees or (if earlier) publicly announces an offer or invitation to buy such share.

The effect of this resolution is to renew the authority granted to the Company to purchase up to 195,285,000 GBP preference shares and up to 15,000 USD preference shares. No preference shares have been repurchased since the last AGM.

While it is important to have a capital base which is adequate to allow the business to grow and which appears to offer an

appropriate balance between risk and profitability, it is equally important that the Company does not carry excessive amounts of capital and that it uses the most appropriate mix of capital instruments on the balance sheet. Having the authority to buy back all the issued preference shares would provide the Company with further flexibility in managing the capital base. Accordingly, the directors believe that it is in the best interests of the Company and its shareholders as a whole to have the authority sought by this resolution. Depending on the structure of any such Buyback, additional authority from shareholders may be required.

The directors intend to keep under review the potential to buy back preference shares, taking into account other investment and funding opportunities.

The authority will be exercised only if the directors believe that to do so would be in the interests of shareholders generally.

If the Company purchases any of its preference shares, those shares will be cancelled.

Notice period for General Meetings

That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.

The notice period required for general meetings of the Company is 21 clear days and this resolution seeks approval to reduce that to a minimum of 14 clear days for any meetings before the next AGM.

The approval will be effective until the Company's next AGM, when it is intended that a similar resolution will be proposed.

The shorter notice period would not be used routinely for such meetings, but only where the flexibility is merited by the business of the meeting and is thought to be to the advantage of shareholders as a whole. The Company will make electronic voting available to all shareholders for any such meeting.

AGMs will require at least 21 clear days' notice.

By order of the Board

Scott Corrigan

Group Company Secretary, Standard Chartered PLC
1 Basinghall Avenue, London EC2V 5DD

Registered in England and Wales number 966425

27 March 2026

General Information

The AGM

The AGM will be held at The Honourable Artillery Company (HAC), Armoury House, West Gate, Bunhill Row, London EC1Y 2BQ, on Thursday 7 May 2026 at 11.00am UK time. Entry to the HAC will only be permitted via the entrance on Bunhill Row.

A map showing the location of the venue can be found below:

The AGM will start promptly at 11.00am UK time; you should allow 30 minutes for security and registration formalities

Registration

Upon arrival, please go to the registration desks which will be clearly signposted. Please bring your shareholder attendance card with you. If you do not have an attendance card, you will need to confirm your name and address details with our registrar prior to admittance.

Guests are not entitled to attend the meeting, but a shareholder may be permitted to bring one guest in limited circumstances at the discretion of the Company.

Shareholders wishing to bring a guest must notify the Company's registrar in advance using the contact details under 'Registrar's details and enquiries' below.

Security

For your safety, security checks will be carried out on entry to the venue, which may include body searches and examining all hand baggage. Please note that you will be asked to leave large bags in the cloakroom. Use of laptops and recording equipment (including cameras) will not be permitted during the AGM. Mobile phones and all other electronic devices should be turned off throughout the AGM. Items which may be used for disruptive purposes, such as banners, costumes, leaflets or whistles, are prohibited. You will not be permitted to take liquids into the venue. Any person who refuses to comply with the appropriate security measures in place may be denied entry into the venue.

Please be aware that we do not permit behaviour that may interfere with anyone's security, safety or the good order of the meeting and unacceptable behaviour will be dealt with appropriately. Anyone who does not comply may be removed from the meeting and the premises.

Refreshments

Light refreshments will be available in the reception areas both before and after the AGM.

Attending the AGM

If you want to attend the AGM and vote, you must be on the Company's register of members in the UK at 10.00pm UK time on 5 May 2026 or on the Company's branch register of members in Hong Kong at 5.00am Hong Kong time on 6 May 2026. If the AGM is adjourned to a time after 11.00am UK time on 7 May 2026, you must be on the Company's register of members in the UK at 10.00pm UK time on the date two business days prior to the day of the adjourned meeting or on the Company's branch register of members in Hong Kong at 5.00am Hong Kong time on the date one business day prior to the day of the adjourned meeting. We will advise you in the notice of any adjourned meeting when you need to be on the register to be able to attend and vote.

All shareholders, proxies and joint shareholders may attend and speak at the AGM. However, in the case of a joint shareholder only the vote of the first-named shareholder present (in person or by proxy) at the AGM shall be accepted.

Changes to the register of members after the relevant deadline will be disregarded in determining the rights of any person to attend and vote at the AGM.

Asking questions

Any member attending the AGM has the right to ask questions. If you wish to ask a question at the AGM, please raise your hand and wait for the Chair of the meeting to invite you to ask your question.

Members can also submit questions in advance of the AGM by sending your question via email to [email protected] before 11.00am UK time on 7 May 2026. Any questions submitted that are not relevant to the business of the AGM will be forwarded for the attention of an appropriate executive. If you have not submitted a question by this deadline, you will still have the opportunity to ask questions at the AGM. Asking questions in advance of the meeting does not affect your rights as a shareholder to attend and speak at the AGM.

The Company must answer questions relating to the business being dealt with at the meeting but no such answer need be given if (a) to do so would interfere unduly with the preparation for the AGM, or involve the disclosure of confidential information, (b) the answer has already been given on a website in the form of an answer to a question, or (c) it is undesirable in the interests of the Company or the good order of the meeting that the question be answered.

Shareholders may follow up on any answers given to a question at the AGM by emailing [email protected].

Access

The venue has full wheelchair access. If you are hard of hearing, an induction loop system will be available in the room. Anyone accompanying a shareholder in need of assistance will be admitted to the AGM. If any shareholder with a disability has a question regarding attendance, please contact Group Corporate Secretariat at Standard Chartered PLC, 1 Basinghall Avenue, London EC2V 5DD (telephone: +44 (0) 20 7885 8888 / email: [email protected]).

First Aid

First aid facilities will be available. Please approach any member of Standard Chartered staff.

Receiving cash dividends

For information on the payment of cash dividends, including default currency options, dividend elections and changing your dividend standing instruction, please see sc.com/shareholders.

Please see below key dates for your information:

Deadline for dividend currency election forms: 16 April 2026.
Deadline for exchange rate calculation on dividend payment: 24 April 2026.

Registrar's details and enquiries

Computershare Investor Services PLC maintain the Company's share register. For enquiries about the AGM or your shareholdings, please contact the relevant registrar below:

UK registered shareholders: Computershare Investor Services PLC. By post: The Pavilions, Bridgwater Road, Bristol BS99 6ZZ. By telephone: +44 (0)370 702 0138 (8.30am to 5.30pm (UK time) Monday to Friday, excluding UK public holidays). Please also refer to www.investorcentre.co.uk/contactus.
Hong Kong registered shareholders: Computershare Hong Kong Investor Services Limited. By post: 17M, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong. By telephone: +852 2862 8555. Please also refer to computershare.com/hk/investors.

Audit statement

Under section 527 of the Companies Act 2006 (the Act), members meeting the threshold requirements in that section may require the Company to publish on a website a statement setting out any matter relating to: (i) the audit of the Company's accounts (including the auditor's report and the conduct of the audit) that are to be laid before the AGM; or (ii) any circumstance connected with an auditor of the Company ceasing to hold office since the previous meeting at which the annual accounts and reports were laid. The Company may not require the shareholders requesting any such website publication to pay its expenses in complying with sections 527 or 528 of the Act. Where the Company is required to place a statement on a website under section 527 of the Act, it must forward the statement to the Company's auditor not later than the time when it makes the statement available on the website. The business which may be dealt with at the AGM includes any statement that the Company has been required under section 527 of the Act to publish on a website.

Website

A copy of the AGM notice and other information required by section 311A of the Act, can be found at sc.com/agm.

Electronic communication

You may not use any electronic address provided in either this AGM notice or any related documents (including the proxy form) to communicate with the Company for any purposes other than those expressly stated.

Inspection of documents

The following documents will be available for inspection at 1 Basinghall Avenue, London, EC2V 5DD and at the offices of our Hong Kong legal advisers, Slaughter and May at 47th Floor, Jardine House, One Connaught Place, Central, Hong Kong from the date of this document until the end of the meeting during normal business hours (excluding public holidays):

copies of the executive directors' contracts of employment;
copies of the Group Chair's and independent non-executive directors' contracts for service;
copies of the directors' deeds of indemnity;
a copy of the current articles of association of the Company.

These documents will also be available at the physical place of the meeting for at least 15 minutes before, and during, the meeting.

Translation

In the case of any conflict between any translation and this English text, this English text shall prevail.

Recording

A full recording of the AGM will not be made available.

Data processing

Attendees are reminded that their personal data may be processed for the purposes of the AGM. Further information can be found in the privacy policy at sc.com/en/privacy-policy.

Preference shareholders

Only ordinary shareholders may attend, speak and vote at the AGM. This document is sent to holders of preference shares for information only.

Information on how to vote

Proxy appointments

If you are an ordinary shareholder you may attend, speak and vote in person at the AGM, or appoint one or more proxy(ies) to exercise all or any of your rights to attend and to speak and vote on your behalf at the AGM. A shareholder may appoint more than one proxy in relation to the AGM provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder. A proxy need not be a shareholder of the Company. Appointing a proxy will not prevent shareholders attending and voting at the AGM should they wish to do so.

A proxy may be appointed by any of the following methods:

Electronic proxy – if you are a shareholder on the UK register or Hong Kong branch register of members you may submit your proxy form(s) electronically. You can appoint your proxy at www.investorcentre.co.uk/eproxy.

You will need the Control Number, your Shareholder Reference Number (SRN), and Personal Identification Number (PIN), which are stated on the accompanying proxy form, voting instruction form or email notification if you receive your communications electronically, to access the service. Your PIN will expire at 11.00am UK time (6.00pm Hong Kong time) on 5 May 2026. You will be asked to agree to the terms and conditions for electronic proxy appointment and it is important that you read these carefully;

Completing and returning the enclosed proxy form to our relevant registrar;
Voting through ShareCare – if you are a shareholder on the UK register and hold your shares in ShareCare, you can use the electronic proxy appointment service (see below); or
CREST electronic proxy – if you are a shareholder on the UK register and a member of CREST you can use the CREST electronic proxy appointment service (see below).

IMPORTANT: Whichever method you choose, any proxy form or other instrument appointing a proxy must be received by the Company's registrar no later than 11.00am UK time (6.00pm Hong Kong time) on 5 May 2026 to be valid.

The Board strongly encourages shareholders to vote on all resolutions by completing their proxy form (or voting instruction form) to appoint the Chair of the AGM to cast their votes as directed. This is to ensure that your vote is counted if you are unable to attend and vote on the day of the AGM.

Voting through ShareCare

For shareholders on the UK register, if you hold your shares in ShareCare, you may submit your voting instruction electronically in the same way as set out above for the electronic appointment of proxies using the Control Number and your ShareCare Number and PIN (which are stated on the accompanying voting instruction form), or you can complete and return the enclosed voting instruction form to our UK registrar. Your PIN will expire at 11.00am UK time on 5 May 2026. Whichever method you choose, any voting instruction form or other instrument appointing a proxy must be received by our registrar no later than 11.00am UK time on 5 May 2026 to be valid.

CREST electronic proxy appointment

For shareholders on the UK register, if you are a CREST member and wish to appoint one or more proxies using the CREST electronic proxy appointment service, you may do so by following the procedures described in the CREST manual (available at euroclear.com/site/public/EUI). If you are a CREST Personal Member or other CREST sponsored member or a CREST member who has appointed a voting service provider, you should refer to your CREST sponsor or voting service provider, who will be able to take the appropriate action on your behalf.

In order for your proxy appointment using CREST to be valid, the appropriate CREST message (a CREST Proxy Instruction) must be properly authenticated in accordance with Euroclear UK & Ireland Limited's specifications and must contain the information required for these instructions, as described in the CREST manual. The message, regardless of whether it constitutes the appointment of a proxy or is an amendment to the instruction given to a previously appointed proxy, must, in order to be valid, be transmitted so as to be received by our agent (ID 3RA50) by 11.00am UK time on 5 May 2026. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Application Host) from which our agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.

CREST members and, where applicable, their CREST sponsors or voting service providers, should note that Euroclear UK & Ireland Limited does not make available special procedures in CREST for any particular message. Normal system timings and limitations will, therefore, apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member, or sponsored member, or has appointed a voting service provider, to procure that their CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting system providers are referred, in particular, to those sections of the CREST manual concerning practical limitations of the CREST system and timings. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in regulation 35(5)(a) of the Uncertificated Securities Regulations 2001, which regulates instructions containing incorrect information and instructions that are improperly sent.

Nominated persons

Any person to whom this document is sent who is a person nominated under section 146 of the Act to enjoy information rights (a Nominated Person) may, under an agreement with the shareholder that nominated them, have a right to be appointed (or to have someone else appointed) as a proxy

for the AGM. If a Nominated Person has no such proxy appointment right or does not wish to exercise it, they may, under any such agreement, have a right to give instructions to the shareholder as to the exercise of voting rights.

The statements under the paragraphs headed 'Proxy appointments' do not apply to Nominated Persons. The rights described in these paragraphs can only be exercised by ordinary shareholders (or by proxy(ies) appointed to act on their behalf) at a general meeting of the Company.

Corporate representatives

Any corporation which is a member can appoint one or more corporate representatives who may exercise on its behalf all of its powers as a member provided that they do not do so in relation to the same shares.

If a corporation intends to appoint one or more corporate representatives please contact Computershare on either [email protected] for UK corporations or [email protected] for Hong Kong corporations.

Poll voting procedure

The Company will call a poll on all resolutions at the AGM to allow the votes of shareholders who have lodged proxies and shareholders who attend the meeting in person to be taken into account. Voting will take place via a personalised poll card, given to all those entitled to vote who attend the AGM once the Chair of the AGM formally declares the poll open.

All the votes made in person will be counted and added to those received by proxy. If you have already voted by proxy you will still be able to vote in person and your vote on the day will replace your proxy vote lodged previously.

On a poll, every ordinary shareholder present in person or by proxy has one vote for every ordinary share of 50 cents each held. As at the Latest Practicable Date, the Company had 2,243,710,167 ordinary shares of 50 cents each in issue, none of which were held in treasury. The ordinary shares carry in aggregate 2,243,710,167 voting rights on a poll.

The results of the poll will be announced to the London Stock Exchange, the Stock Exchange of Hong Kong Limited, and published on our website at sc.com/en/investors/stock-exchange-announcements following the conclusion of the meeting.

Following a poll vote, any shareholder who has voted on the poll is entitled under section 360BA of the Act to request from the Company information which will allow them to determine whether their vote was validly recorded and counted.

Appendix: ECAT 1 Securities

Equity Convertible Additional Tier 1 Securities

The Company must meet minimum regulatory capital requirements applicable to it in the jurisdictions in which it operates.

Under the UK Capital Requirements Regulation (CRR), the Company must hold a minimum amount of Tier 1 capital, calculated as a specified percentage of its Risk Weighted Assets on a consolidated basis. To maintain an efficient capital structure under relevant prudential regulatory requirements, the Company can choose to meet part of that minimum requirement by issuing Additional Tier 1 instruments (AT1 Securities) instead of Common Equity Tier 1 capital (CET1).

In order to qualify as Additional Tier 1 capital, the terms and conditions of the AT1 Securities must contain a provision under which, on the occurrence of a Trigger Event (which is the breach of a pre-determined CET1 capital ratio) the principal amount of the AT1 Securities is either written down or converted into CET1. Under the rulebook of the Prudential Regulation Authority (PRA), AT1 Securities must convert to equity or be written down when the issuer's CET1 ratio is below 5.125 per cent; in practice, for UK issuers, the PRA currently requires this CET1 ratio trigger to be set at 7 per cent or higher.

The Company will take into account various factors when deciding whether to issue AT1 Securities, including the capital position of the Company at the time, the applicable regulatory capital requirements and its view of the likely capital requirements in the longer term. The timing and terms of issuance of AT1 Securities will be determined by the Company and, where appropriate, in consultation with the PRA.

The flexibility to issue AT1 Securities enables the Company to achieve diversification and efficiency in its capital base.

Shareholder approval is being sought in resolutions 19 and 22 to authorise the issue of AT1 Securities which convert into ordinary shares (Equity Convertible Additional Tier 1 Securities or ECAT1 Securities) on the occurrence of a Trigger Event and/or shares to be issued on conversion or exchange of those ECAT1 Securities.

Why is the Company seeking a specific mandate to issue ECAT1 Securities?

The Company is seeking a specific mandate to enable it to issue ECAT1 Securities and the mandate would be used for that sole purpose (i.e. the Company could not use this specific mandate to issue new shares for any other purpose). The general mandate under resolution 17 may be used by the Company to issue new shares at any time on a non-preemptive basis, subject to the limits under that resolution and restrictions under the UK and Hong Kong Listing Rules and Investment Association guidelines. The specific mandate for ECAT1 Securities will provide greater flexibility for the Company in allowing it to maintain a general mandate for other purposes. By the same token, the general mandate under resolution 17 would not be used in connection with the issue of ECAT1 Securities.

The Company believes it would not be practical to obtain a specific mandate from shareholders to issue ECAT1 Securities only when the need arises, primarily due to the time it would take to prepare the relevant circular to shareholders and convene the general meeting to seek shareholder approval.

Having a pre-approved mandate will enable the Company to act on a timely basis to satisfy the capital requirements when market conditions are conducive to successfully launching and completing the issue.

What steps can the Company take before or on a Trigger Event?

In advance of and on a Trigger Event the Company's management can be expected to take certain actions:

i) Recovery planning – the Company is required by its regulators to develop and maintain a Recovery Plan to be implemented in the event of financial stress. Should the Company's capital ratios fall by levels specified in the Recovery Plan, the Company is likely to be required to implement those planned recovery actions to improve its capital position (e.g. by reducing Risk Weighted Assets and/or through a rights issue of ordinary shares or an issuance of other eligible capital instruments) in advance of a Trigger Event.

ii) Shareholder participation – despite the recovery actions mentioned above having been taken, the Board may give shareholders the opportunity to purchase the ordinary shares issued on conversion or exchange of any ECAT1 Securities on a pro rata basis, where practicable, as permitted by the terms of the relevant instruments and subject to applicable laws and regulations, at the same price as the holders of the ECAT1 Securities would otherwise have acquired those ordinary shares had they not acquired them by conversion (i.e. at the conversion price described below). This will be determined on a transaction-by-transaction basis and the mechanism for shareholder participation will be written into the terms and conditions of the ECAT1 Securities where applicable.

The circumstances in which a Trigger Event might be expected to occur are currently considered to be remote given the level of capital the Company currently holds in excess of the expected Trigger Event ratio and the recovery actions that it has available to it should such a situation seem likely to arise.

As at 31 December 2025, the Company had USD 34 billion of Common Equity Tier 1 Capital and a Common Equity Tier 1 ratio of 14 per cent. This level of capital is considerably in excess of the expected Trigger Event ratio.

How do ECAT1 Securities provide a more efficient capital structure?

The issuance of ECAT1 Securities allows the Company to increase its Tier 1 capital (up to regulatory eligibility limits) in a tax and capital efficient manner and without diluting its existing shareholder base.

At what price will the ECAT1 Securities be issued?

The pricing mechanism for ECAT1 Securities is similar to other fixed income capital instruments that the Company would issue. The issue price of the ECAT1 Securities will be fixed immediately prior to issuance taking into account prevailing market convention.

At what price will the ECAT1 Securities be converted into or exchanged for ordinary shares?

The terms and conditions of the ECAT1 Securities will specify a conversion price or a mechanism for setting a conversion price (which could include a variable conversion price determined

by reference to the prevailing market price on conversion subject to a minimum "floor" conversion price).

The conversion price is the rate at which the ECAT1 Securities will be exchanged for ordinary shares on the occurrence of a Trigger Event. The conversion price or (as applicable) the minimum "floor" conversion price may be set at a discount to the price of the Company's ordinary shares immediately prior to issuance of the ECAT1 Securities. The extent of the discount will be determined taking into account prevailing market convention.

The determination of whether a fixed or variable conversion price structure is adopted will be made by the Company having regard to, among others, prevailing market conditions and compliance with any applicable PRA requirements at the time of issuance of the relevant ECAT1 Securities.

Will the ECAT1 Securities be redeemable?

Yes. The PRA rulebook requires AT1 capital instruments to be perpetual and any early redemption of the ECAT1 Securities would be subject to the prior consent of the PRA. For example, the terms of the ECAT1 Securities will likely include provisions so that the Company may redeem the ECAT1 Securities (i) after a fixed period of time (minimum five years) upon an interest rate reset date; (ii) in the event of a change in the regulatory classification of the ECAT1 Securities such that they can no longer be included in the Company's Tier 1 capital; or (iii) as a result of a change in the tax treatment of the ECAT1 Securities.

How have you calculated the size of the authorities you are seeking?

The size of the authorities reflected in resolutions 19 and 22 has been calculated based on anticipated capital requirements to provide flexibility in capital management.

The resolutions give the Board authority to set the specific terms of the ECAT1 Securities, which may provide for write-down or conversion. The authorities sought are set at a level to provide full flexibility to the Company in managing its capital structure efficiently given the uncertainties that remain in both the precise regulatory requirements applicable and the market for this form of capital instrument. The specific mandate will give the Board authority to allot ordinary shares and grant rights to subscribe for or convert any security into ordinary shares in the Company representing up to a further 15 per cent of the Company's issued ordinary share capital as at 13 March 2026. This limit has been calculated based on internal modelling to provide sufficient flexibility to the Company, taking into account potential fluctuations in the Company's share price, the GBP/ USD exchange rates and inflation in the Group's risk-weighted assets. The two issues of ECAT1 Securities of the Company made pursuant to the 2016 and 2019 Mandates were made at a conversion price discount factor of 10 per cent. The two issues of ECAT1 Securities of the Company made pursuant to the 2020 Mandate, one issue of

ECAT1 Securities of the Company made pursuant to the 2021 Mandate, one issue of ECAT1 Securities made pursuant to the 2022 Mandate, one issue of ECAT1 Securities made pursuant to the 2023 Mandate, two issues of ECAT1 Securities made pursuant to the 2024 Mandate and two issues of ECAT1 Securities made pursuant to the 2025 Mandate were made at a conversion price equivalent to the then prevailing share price of the Company.

The same approach is currently expected to be followed for future issuances of ECAT 1 Securities under the 2026 Mandate, that are issued using the fixed conversion price structure.

Hong Kong Stock Exchange waiver

Under Rule 13.36(1) of the Hong Kong Listing Rules (HKLR), the directors of a company must obtain the consent of shareholders in a general meeting prior to allotting or issuing shares or securities convertible into shares except as set out under Rule 13.36(2)(b). Rule 13.36(2)(b) of the HKLR allows the directors to seek a general mandate from shareholders to allot or issue shares on a non pre-emptive basis. As explained above, the Company is seeking this specific mandate from shareholders in addition to the general mandate under Rule 13.36(2)(b) of the HKLR for the sole purpose of issuing ECAT1 Securities. This specific mandate would require a dispensation from Rule 13.36(1) of the HKLR. On 4 March 2026, the Hong Kong Stock Exchange granted such a waiver to allow the directors to seek the authority under resolution 19 and resolution 22 in relation to issuing ECAT1 Securities.

If approved by shareholders, the specific mandate would continue in force until:

i) the end of next year's AGM (or, if earlier, at the close of business on 6 August 2027) at which time it will lapse unless the specific mandate is renewed, either unconditionally or subject to conditions; or
ii) revoked or varied by ordinary resolution of the shareholders in a general meeting.

As at the date of this announcement, the Board of Directors of Standard Chartered PLC comprises:

Chair:
Maria da Conceicao das Neves Calha Ramos

Executive Director:
William Thomas Winters, CBE (Group Chief Executive)

Independent Non-Executive Directors:
Shirish Moreshwar Apte; Jacqueline Hunt; Diane Enberg Jurgens; Robin Ann Lawther, CBE; Lincoln Leong Kwok Kuen; Philip George Rivett (Senior Independent Director); David Tang and Linda Yi-chuang Yueh, CBE